ReviewLeukemia & lymphoma2024

Challenges identifying DLBCL patients with poor outcomes to upfront chemoimmunotherapy and its impact on frontline clinical trials.

Suheil Albert Atallah-Yunes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.